Photodynamic Therapy Devices Market Size
Photodynamic therapy devices market size was valued at USD 2.1 billion in 2024 and is expected to grow at a CAGR of 24.8% to reach USD 15.8 billion by 2034
Medical technology's niche market is photodynamic treatment equipment. It serves PDT equipment, which combines light and medications called photosensitizers. These medications specifically target cells, and when they react to light from the PDT device, they release molecules known as reactive oxygen species (ROS), which cause the targeted cells to die. This treatment is very appealing for treating skin cancer due to its less invasive nature, but it also has much potential for treating psoriasis and acne. Increased cancer occurrences, expanding PDT applications across a range of therapeutic domains, and advancements in light sources, delivery methods, and photosensitizer medications will propel the PDT devices market, which is anticipated to experience rapid growth in the near future.
With its accuracy and focus on treating a wide range of medical conditions, PDT is expected to become an increasingly popular therapy choice in the years to come. One of the most common malignancies in the world, skin cancer is becoming more common. PDT is a valuable treatment option for several skin malignancies, including squamous and basal cell carcinomas. The primary driver of the PDT device market is the growing need for skin cancer therapy. Apart from treating psoriasis and acne vulgaris, PDT has also been modified to treat actinic keratosis, a precancerous condition. This considerably expands the market for PDT devices because it provides treatment for a greater variety of disorders.